Rare Diseases & Orphan Drugs

The Role of Artificial Intelligence in Rare Disease Research

Artificial intelligence (AI) has the potential to revolutionize rare disease research by accelerating diagnosis, drug discovery, and personalized treatments. AI algorithms can analyze large amounts of data, including genetic data, imaging, and clinical records, to identify patterns and potential disease associations. This technology can help clinicians diagnose rare diseases earlier, predict disease progression, and develop targeted treatments. AI can also streamline drug discovery by identifying potential drug targets and predicting drug efficacy. Collaborations between AI companies, researchers, and patient advocacy groups are essential to leverage this technology's potential for rare disease research. However, ensuring ethical and transparent use of AI is critical to maintaining patient trust and advancing research.